Quotient Clinical Signs Cocrystal Agreement with Nuformix

News   Oct 19, 2017

 
Quotient Clinical Signs Cocrystal Agreement with Nuformix
 
 
 

RELATED ARTICLES

Working Together Helps Phage Overcome CRISPR

News

Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.

READ MORE

UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPO

News

MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).

READ MORE

Synthetic Material That Detects Enzymatic Activity

News

Scientists integrate protein and polymer building blocks to create stimulus-responsive systems

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy